Invention Grant
- Patent Title: Composition with non-digestible oligosaccharides for attenuating nasal epithelial inflammation
-
Application No.: US17590588Application Date: 2022-02-01
-
Publication No.: US12023347B2Publication Date: 2024-07-02
- Inventor: Jeroen Van Bergenhenegouwen , Johan Garssen , Claudia Traidl-Hoffmann , Caroline Schlumprecht
- Applicant: Jeroen Van Bergenhenegouwen , Johan Garssen , Claudia Traidl-Hoffmann , Caroline Schlumprecht
- Applicant Address: NL Utrecht
- Assignee: Jeroen Van Bergenhenegouwen,Johan Garssen,Claudia Traidl-Hoffmann,Caroline Schlumprecht
- Current Assignee: Jeroen Van Bergenhenegouwen,Johan Garssen,Claudia Traidl-Hoffmann,Caroline Schlumprecht
- Current Assignee Address: NL Utrecht
- Agency: Foley & Lardner LLP
- Agent Sunit Talapatra
- Priority: EP 159857 2017.03.08
- Main IPC: A61K31/702
- IPC: A61K31/702 ; A61K9/00 ; A61K31/00 ; A61P11/02
Abstract:
The present invention relates to the use of non-digestible oligosaccharides for the direct attenuation of nasal epithelial inflammation, in particular for non-allergic rhinitis, in particular for use in infants.
Public/Granted literature
- US20220152066A1 COMPOSITION WITH NON-DIGESTIBLE OLIGOSACCHARIDES FOR ATTENUATING NASAL EPITHELIAL INFLAMMATION Public/Granted day:2022-05-19
Information query
